Avoidance-suppressing effect of antipsychotic drugs is progressively potentiated after repeated administration: An interoceptive drug state mechanism

Journal of Psychopharmacology

Volumn 24, Issue 7, 2010, Pages 1045-1053

  Mead, A ^a   Li, M ^a  

^a UNIVERSITY OF NEBRASKA LINCOLN   (United States)

Author keywords

Conditioned avoidance response; Drug memory; Haloperidol; Interoceptive drug state; Olanzapine; Rat; Risperidone

Indexed keywords

CHLORDIAZEPOXIDE; CITALOPRAM; HALOPERIDOL; NEUROLEPTIC AGENT; OLANZAPINE; RISPERIDONE;

ANIMAL BEHAVIOR; ARTICLE; DRUG EFFECT; DRUG RESPONSE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; TRAINING;

ANIMALS; ANTIPSYCHOTIC AGENTS; AVOIDANCE LEARNING; BENZODIAZEPINES; CONDITIONING, OPERANT; DOSE-RESPONSE RELATIONSHIP, DRUG; HALOPERIDOL; INJECTIONS, SUBCUTANEOUS; MALE; MEMORY; PSYCHOTROPIC DRUGS; RATS; RATS, SPRAGUE-DAWLEY; RISPERIDONE;

EID: 77953800876     PISSN: 02698811     EISSN: 14617285     Source Type: Journal    
DOI: 10.1177/0269881109102546     Document Type: Article

References (38)

1. Agid, O., Kapur, S., Arenovich, T., Zipursky, RB (2003) Delayed-onset hypothesis of antipsychotic action: a hypothesis tested and rejected. Arch Gen Psychiatry 60: 1228-1235.
2. Agid, O., Seeman, P., Kapur, S. (2006) The "delayed onset" of antipsychotic action-an idea whose time has come and gone. J Psychiatry Neurosci 31: 93-100.
3. Aravagiri, M., Teper, Y., Marder, SR (1999) Pharmacokinetics and tissue distribution of olanzapine in rats. Biopharm Drug Dispos 20: 369-377.
4. Arnt, J. (1982) Pharmacological specificity of conditioned avoidance response inhibition in rats: inhibition by neuroleptics and correlation to dopamine receptor blockade. Acta Pharmacol Toxicol (Copenh) 51: 321-329.
5. Bateup, HS, Svenningsson, P., Kuroiwa, M., Gong, S., Nishi, A., Heintz, N., et al. (2008) Cell type-specific regulation of DARPP-32 phosphorylation by psychostimulant and antipsychotic drugs. Nat Neurosci 11: 932-939.
6. Bolles, RC (1970) Species-specific defense reactions and avoidance learning. Psychol Rev 77: 32-48.
7. Cheng, YF, Paalzow, LK (1992) Linear pharmacokinetics of haloperidol in the rat. Biopharm Drug Dispos 13: 69-76.
8. Emsley, R., Rabinowitz, J., Medori, R. (2006) Time course for antipsychotic treatment response in first-episode schizophrenia. Am J Psychiatry 163: 743-745.
9. Glick, ID, Shkedy, Z., Schreiner, A. (2006) Differential early onset of therapeutic response with risperidone vs conventional antipsychotics in patients with chronic schizophrenia. Int Clin Psychopharmacol 21: 261-266.
10. Goudie, AJ, Smith, JA, Taylor, A., Taylor, MA, Tricklebank, MD (1998) Discriminative stimulus properties of the atypical neuroleptic clozapine in rats: tests with subtype selective receptor ligands. Behav Pharmacol 9: 699-710.
11. Grande, C., Zhu, H., Martin, AB, Lee, M., Ortiz, O., Hiroi, N., et al. (2004) Chronic treatment with atypical neuroleptics induces striosomal FosB/DeltaFosB expression in rats. Biol Psychiatry 55: 457-463.
12. Kapur, S. (1998) A new framework for investigating antipsychotic action in humans: lessons from PET imaging. Mol Psychiatry 3: 135-140.
13. Kapur, S. (2003) Psychosis as a state of aberrant salience: a framework linking biology, phenomenology, and pharmacology in schizophrenia. Am J Psychiatry 160: 13-23.
14. Kapur, S., Arenovich, T., Agid, O., Zipursky, R., Lindborg, S., Jones, B. (2005) Evidence for onset of antipsychotic effects within the first 24 hours of treatment. Am J Psychiatry 162: 939-946.
15. Kapur, S., VanderSpek, SC, Brownlee, BA, Nobrega, J. (2003) Antipsychotic dosing in preclinical models is often unrepresentative of the clinical condition: a suggested solution based on in vivo occupancy. J Pharmacol Exp Ther 305: 1-7.
16. Kippin, TE, Kapur, S., van der Kooy, D. (2005) Dopamine specifically inhibits forebrain neural stem cell proliferation, suggesting a novel effect of antipsychotic drugs. J Neurosci 25: 5815-5823.
17. Konradi, C., Heckers, S. (2001) Antipsychotic drugs and neuroplasticity: insights into the treatment and neurobiology of schizophrenia. Biol Psychiatry 50: 729-742.
18. Leucht, S., Busch, R., Hamann, J., Kissling, W., Kane, JM (2005) Early-onset hypothesis of antipsychotic drug action: a hypothesis tested, confirmed and extended. Biol Psychiatry 57: 1543-1549.
19. Li, M., Fletcher, PJ, Kapur, S. (2007) Time course of the antipsychotic effect and the underlying behavioral mechanisms. Neuropsychopharmacology 32: 263-272.
20. Li, M., He, W., Mead, A. (2009) Olanzapine and risperidone disrupt conditioned avoidance responding in phencyclidine or amphetamine pretreated rats by selectively weakening motivational salience of conditioned stimulus. Behav Pharmacol 20: 84-98.
21. Maes, JH, Vossen, JM (1997) Conditional control by midazolam and amphetamine in a rapid appetitive discrimination procedure. Eur J Pharmacol 319: 5-11.
22. Mead, A., Li, M., Kapur, S. (2008) Clozapine and olanzapine exhibit an intrinsic anxiolytic property in two conditioned fear paradigms: contrast with haloperidol and chlordiazepoxide. Pharmacol Biochem Behav 90: 551-562.
23. Miyamoto, S., Duncan, GE, Marx, CE, Lieberman, JA (2005) Treatments for schizophrenia: a critical review of pharmacology and mechanisms of action of antipsychotic drugs. Mol Psychiatry 10: 79-104.
24. Natesan, S., Reckless, GE, Nobrega, JN, Fletcher, PJ, Kapur, S. (2006) Dissociation between in vivo occupancy and functional antagonism of dopamine D2 receptors: comparing aripiprazole to other antipsychotics in animal models. Neuropsychopharmacology 31: 1854-1863.
25. Nguyen, TV, Kosofsky, BE, Birnbaum, R., Cohen, BM, Hyman, SE (1992) Differential expression of c-fos and zif268 in rat striatum after haloperidol, clozapine, and amphetamine. Proc Natl Acad Sci U S A 89: 4270-4274.
26. Overton, DA (1979) Preclinical measurement of the amount of state-dependent learning produced by psychoactive drugs [proceedings]. Psychopharmacol Bull 15: 51-52.
27. Porter, JH, Prus, AJ, Vann, RE, Varvel, SA (2005) Discriminative stimulus properties of the atypical antipsychotic clozapine and the typical antipsychotic chlorpromazine in a three-choice drug discrimination procedure in rats. Psychopharmacology (Berl) 178: 67-77.
28. Porter, JH, Varvel, SA, Vann, RE, Philibin, SD, Wise, LE (2000) Clozapine discrimination with a low training dose distinguishes atypical from typical antipsychotic drugs in rats. Psychopharmacology (Berl) 149: 189-193.
29. Raedler, TJ, Schreiner, A., Naber, D., Wiedemann, K. (2007) Early onset of treatment effects with oral risperidone. BMC Psychiatry 7: 4.
30. Remington, G., Seeman, P., Shammi, C., Mann, S., Kapur, S. (2005) " Extended" antipsychotic dosing: rationale and pilot data. J Clin Psychopharmacol 25: 611-613.
31. Robertson, GS, Fibiger, HC (1992) Neuroleptics increase c-fos expression in the forebrain: contrasting effects of haloperidol and clozapine. Neuroscience 46: 315-328.
32. Robertson, GS, Matsumura, H., Fibiger, HC (1994) Induction patterns of Fos-like immunoreactivity in the forebrain as predictors of atypical antipsychotic activity. J Pharmacol Exp Ther 271: 1058-1066.
33. Samaha, AN, Reckless, GE, Seeman, P., Diwan, M., Nobrega, JN, Kapur, S. (2008) Less is more: antipsychotic drug effects are greater with transient rather than continuous delivery. Biol Psychiatry 64: 145-152.
34. Samaha, AN, Seeman, P., Stewart, J., Rajabi, H., Kapur, S. (2007) " Breakthrough" dopamine supersensitivity during ongoing antipsychotic treatment leads to treatment failure over time. J Neurosci 27: 2979-2986.
35. Schechter, MD, Cook, PG (1975) Dopaminergic mediation of the interoceptive cue produced by d-amphetamine in rats. Psychopharmacologia 42: 185-193.
36. Sun, T., Hu, G., Li, M (2009) Repeated antipsychotic treatment progressively potentiates inhibition on phencyclidine-induced hyperlocomotion, but attenuates inhibition on amphetamine-induced hyperlocomotion: relevance to animal models of antipsychotic drugs. Eur J Pharmacol 602: 334-342.
37. van Beijsterveldt, LE, Geerts, RJ, Leysen, JE, Megens, AA, Van den Eynde, HM, Meuldermans, WE, et al. (1994) Regional brain distribution of risperidone and its active metabolite 9-hydroxy-risperidone in the rat. Psychopharmacology (Berl) 114: 53-62.
38. Wadenberg, ML, Soliman, A., VanderSpek, SC, Kapur, S. (2001) Dopamine D(2) receptor occupancy is a common mechanism underlying animal models of antipsychotics and their clinical effects. Neuropsychopharmacology 25: 633-641.